Prospective study of early enteral feeding utilizing arginine after total gastrectomy and pancreaticoduodenectomy

Prospective study of early enteral feeding utilizing arginine after total gastrectomy and pancreaticoduodenectomy - Prospective study of early enteral feeding utilizing arginine after total gastrectomy and pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026770

Enrollment

Registered

2017-03-30

Start date

2010-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

after total gastrectomy and pancreaticoduodenectomy

Interventions

parenteral nutrition (PN) alone (PN group) early enteral arginine-rich nutrition (EAN) supplemented with parenteral nutrition (EAN group)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: gastrectomy for curative intent PANCREATICODUODENECY

Exclusion criteria

Exclusion criteria: no operation

Design outcomes

Primary

Measure	Time frame
evaluate the clinical and economic usufulness of the early tube enteral nutrition after total gastrectomy and pancreaticoduodenectomy comparing the classical total parenteral nutrition, especially paying attention to a special amino acid, arginine.	—

Countries

Japan

Contacts

Public ContactYasuko Okamoto

Hamamatsu Medical Center Clinical Nutritional Management

j08nuua38c@hi3.enjoy.ne.jp0534537111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026